Sorrento Therapeutics, Inc. announced updated positive results from its Phase Ib study of human allogeneic adipose-derived MSCs for patients suffering from COVID-19-induced acute respiratory distress (ARD) or acute respiratory distress syndrome (ARDS).
[Sorrento Therapeutics, Inc. ]
6445212 nan items 1 apa default asc 1
Cynata Therapeutics Limited announced that it has received ethics committee approval to expand recruitment criteria in its active MEseNchymal coviD-19 (MEND) clinical trial.
[Cynata Therapeutics Limited (GlobeNewswire)]
6445212 nan items 1 apa default asc 1
The authors critically discuss advancements and shortfalls of scaffold-free cell-based tissue engineering strategies, along with pioneering concepts that have the potential to transform regenerative and reparative medicine.
[NPJ Regenerative Medicine]
Advances are being made in cell-manufacturing approaches that have the potential to establish cell-therapies as credible therapeutic options. T-cell therapies face many challenges but hold great promise for improving clinical outcomes for patients with solid tumours.
[British Journal of Cancer]
6445218 36MP8IL5 items 1 apa default asc 1
Morotti, M., Albukhari, A., Alsaadi, A., Artibani, M., Brenton, J. D., Curbishley, S. M., Dong, T., Dustin, M. L., Hu, Z., McGranahan, N., Miller, M. L., Santana-Gonzalez, L., Seymour, L. W., Shi, T., Van Loo, P., Yau, C., White, H., Wietek, N., Church, D. N., … Ahmed, A. A. (2021). Promises and challenges of adoptive T-cell therapies for solid tumours. British Journal of Cancer, 1–18. https://doi.org/10.1038/s41416-021-01353-6 Cite
Scientist found that only when human photoreceptor precursor cells were pre‐incubated with PKX‐001 prior to transplantation, did the cells integrate and mature into cone photoreceptors expressing S‐opsin or L/M opsin.
[Journal of Tissue Engineering and Regenerative Medicine]
6445218 92MJP799 items 1 apa default asc 1
Viringipurampeer, I. A., Yanai, A., Nizamudheen, V. S., Gregory‐Evans, C. Y., & Gregory‐Evans, K. (n.d.). Photoreceptor precursor cell integration into rodent retina after treatment with novel glycopeptide PKX-001. Journal of Tissue Engineering and Regenerative Medicine, n/a(n/a). https://doi.org/https://doi.org/10.1002/term.3193 Cite
Reduction of protein/creatinin was observed in p53sh‐endothelial progenitor cell (EPC)‐transplanted mice more than null‐EPC or null‐mouse mesenchymal stromal cell transplanted mice.
[Journal of the American Heart Association]
6445212 5I7GVHS2 items 1 apa default asc 1
Kundu Nabanita, Nandula Seshagiri R., Asico Laureano D., Fakhri Mona, Banerjee Jaideep, Jose Pedro A., & Sen Sabyasachi. (n.d.). Transplantation of Apoptosis‐Resistant Endothelial Progenitor Cells Improves Renal Function in Diabetic Kidney Disease. Journal of the American Heart Association, 0(0), e019365. https://doi.org/10.1161/JAHA.120.019365 Cite
A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding of the impact of cellular therapeutics in vivo requires advanced immune monitoring strategies.
[Frontiers in Immunology]
Researchers identified the insulin gene enhancer binding protein‐1 (ISL-1) protein as a potential modulator in bone marrow‐derived mesenchymal stem cell (BMSC)‐mediated revascularization of islet grafts. They demonstrated that the survival rate and insulin secretion of islets were increased in the presence of BMSCs, indicating that BMSCs promoted islet revascularization in a coculture system and rat diabetes model.
1254621 NEG6DWII items 1 apa default asc 1
Wang, Y., Wang, J.-W., Li, Y., Tian, X.-H., Feng, X.-S., Zhang, S.-C., Liu, P.-J., Xue, W.-J., Zheng, J., & Ding, X.-M. (n.d.). Bone marrow-derived mesenchymal stem cells improve rat islet graft revascularization by upregulating ISL1. STEM CELLS, n/a(n/a). https://doi.org/https://doi.org/10.1002/stem.3378 Cite
Scientists developed CRISPR/Cas9 strategies to prevent aminoglycoside-induced deafness, a common type of acquired non-inherited sensorineural hearing loss, via disrupting the Htra2 gene in the inner ear which is involved in apoptosis but has not been investigated in cochlear hair cell protection.
Investigators evaluated the bone regeneration potential of nanohydroxyapatite/chitosan/gelatin three-dimensional porous scaffold with human periodontal ligament stem cells in critical-sized jaw bone defects in minipigs.
[Stem Cells and Development]
1254621 85RC8SX7 items 1 apa default asc 1
The authors take a closer look at the commercial CAR-T cell therapies, as well as on CAR-T and CAR-NK cell products, which are currently under evaluation in clinical trials, that are being conducted in Germany.